BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen S, Gao C, Du Q, Tang L, You H, Dong Y. A prognostic model for elderly patients with squamous non-small cell lung cancer: a population-based study. J Transl Med 2020;18:436. [PMID: 33198777 DOI: 10.1186/s12967-020-02606-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang F, Li Y, Li Z, Zou Z, Lu Y, Xu C, Zhao Z, Wang H, Wang Y, Guo S, Jin L, Wang J, Li Q, Jiang G, Xia F, Shen B, Wu J. Prognostic value of GPC5 polymorphism rs2352028 and clinical characteristics in Chinese lung cancer patients. Future Oncol 2022. [PMID: 36165234 DOI: 10.2217/fon-2022-0319] [Reference Citation Analysis]
2 Kang SW, Jeong WG, Lee JE, Oh IJ, Song SY, Lee BC, Kim YH. Prognostic significance of location index in resected T1-sized early-stage non-small cell lung cancer. Acta Radiol 2022;:2841851221111678. [PMID: 35815698 DOI: 10.1177/02841851221111678] [Reference Citation Analysis]
3 Sun H, Liu M, Yang X, Ren Y, Dai H, Wang C. Construction and validation of prognostic nomograms for elderly patients with metastatic non-small cell lung cancer. Clin Respir J 2022;16:380-93. [PMID: 35514033 DOI: 10.1111/crj.13491] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Chinchilla-Tábora LM, Sayagués JM, González-Morais I, Rodríguez M, Ludeña MD. Prognostic Impact of EGFR Amplification and Visceral Pleural Invasion in Early Stage Pulmonary Squamous Cell Carcinomas Patients after Surgical Resection of Primary Tumor. Cancers (Basel) 2022;14:2174. [PMID: 35565304 DOI: 10.3390/cancers14092174] [Reference Citation Analysis]
5 Ye X, Liu Y, Yang J, Wang Y, Cui X, Xie H, Song L, Ding Z, Zhai R, Han Y, Yang L, Zhang H. Do older patients with stage IB non-small-cell lung cancer obtain survival benefits from surgery? A propensity score matching study using SEER data. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.03.015] [Reference Citation Analysis]
6 Cho SW, Jeong WG, Lee JE, Oh I, Song SY, Park HM, Lee H, Kim Y. Clinical implication of interstitial lung abnormality in elderly patients with early‐stage non‐small cell lung cancer. Thoracic Cancer. [DOI: 10.1111/1759-7714.14341] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Wang Y, Lin X, Sun D. A narrative review of prognosis prediction models for non-small cell lung cancer: what kind of predictors should be selected and how to improve models? Ann Transl Med 2021;9:1597. [PMID: 34790803 DOI: 10.21037/atm-21-4733] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Lu T, Zhang L, Chen M, Zheng X, Jiang K, Zheng X, Li C, Xiao W, Miao Q, Yang S, Lin G. Intrapulmonic Cavity or Necrosis on Baseline CT Scan Serves as an Efficacy Predictor of Anti-PD-(L)1 Inhibitor in Advanced Lung Squamous Cell Carcinoma. Cancer Manag Res 2021;13:5931-9. [PMID: 34354375 DOI: 10.2147/CMAR.S319480] [Reference Citation Analysis]